sr141716 has been researched along with Hypotension in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 7 (70.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adolfs, TJ; Coolen, HK; de Jong, NM; den Hartog, AP; Dijksman, JA; Herremans, AH; Hoogendoorn, J; Keizer, HG; Kruse, CG; Lange, JH; McCreary, AC; Ronken, E; Stork, B; Tipker, K; van Stuivenberg, HH; Veerman, W; Verveer, PC; Wals, HC | 1 |
Adolfs, TJ; Borst, AJ; Coolen, HK; de Looff, W; Keizer, HG; Kruse, CG; Lange, JH; McCreary, AC; van Stuivenberg, HH; Veerman, W; Verveer, PC; Wals, HC | 1 |
Borst, AJ; Kruse, CG; Lange, JH; van der Neut, MA; van Stuivenberg, HH; van Vliet, BJ; Yildirim, M | 1 |
Maccallini, C; Macedonio, G; Mirzaie, S; Mollica, A; Novellino, E; Stefanucci, A | 1 |
Cheer, JF; Cutrera, RA; Feleder, C; Millington, WR; Parsons, LH; Stouffer, DG; Villanueva, A; Yilmaz, SM | 1 |
Hou, LC; Ji, GL; Li, N; Lu, Y; Wang, YM; Xie, KL; Xiong, LZ; Zheng, LN | 1 |
Niederhoffer, N; Schmid, K; Szabo, B | 1 |
Bátkai, S; Járai, Z; Kunos, G; Pacher, P; Wagner, JA | 1 |
Bridgen, DT; Kunos, G; Varga, K; Wagner, JA | 1 |
Bonner, TI; Goparaju, SK; Járai, Z; Kunos, G; Razdan, RK; Sugiura, T; Wagner, JA; Wang, L; Zimmer, A; Zimmer, AM | 1 |
1 review(s) available for sr141716 and Hypotension
Article | Year |
---|---|
Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools.
Topics: Analgesics; Animals; Cannabinoids; Endocannabinoids; Hemoglobins; Hypotension; Peptide Fragments; Piperidines; Protein Binding; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, mu; Rimonabant | 2016 |
9 other study(ies) available for sr141716 and Hypotension
Article | Year |
---|---|
Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB(1) cannabinoid receptor antagonists.
Topics: Administration, Oral; Animals; Arachidonic Acid; Binding, Competitive; Biological Availability; CHO Cells; Cricetinae; Crystallography, X-Ray; Fever; Humans; Hypotension; Male; Mice; Models, Molecular; Molecular Conformation; Pyrazoles; Radioligand Assay; Rats; Receptor, Cannabinoid, CB1; Stereoisomerism; Structure-Activity Relationship; Sulfonamides | 2004 |
Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists.
Topics: Administration, Oral; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclohexanols; Hypotension; Hypothermia; Imidazoles; Mice; Models, Molecular; Molecular Conformation; Piperidines; Pyrazoles; Radioligand Assay; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Triazoles | 2005 |
Probing the cannabinoid CB1/CB2 receptor subtype selectivity limits of 1,2-diarylimidazole-4-carboxamides by fine-tuning their 5-substitution pattern.
Topics: Administration, Oral; Aminoimidazole Carboxamide; Animals; Disease Models, Animal; Drug Inverse Agonism; Hypotension; Imidazoles; Mice; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Sulfones | 2010 |
Central cannabinoid 1 receptor antagonist administration prevents endotoxic hypotension affecting norepinephrine release in the preoptic anterior hypothalamic area.
Topics: Animals; Anterior Hypothalamic Nucleus; Arachidonic Acids; Blood Pressure; Endocannabinoids; Endotoxins; Hypotension; Lipopolysaccharides; Macrophages; Male; Neurons; Norepinephrine; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Tumor Necrosis Factor-alpha | 2009 |
CB1 cannabinoid receptor participates in the vascular hyporeactivity resulting from hemorrhagic shock in rats.
Topics: Animals; Blotting, Western; Gene Expression Regulation; Hypotension; Male; Piperidines; Pyrazoles; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; Shock, Hemorrhagic; Survival Rate | 2009 |
The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression.
Topics: Animals; Atropine Derivatives; Benzoxazines; Bradycardia; Cannabinoids; Cardiovascular System; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Hypotension; Male; Medulla Oblongata; Microinjections; Morpholines; Naphthalenes; Norepinephrine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Sympathetic Fibers, Postganglionic; Sympathetic Nervous System | 2003 |
Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors.
Topics: Animals; Cannabinoids; Endotoxins; Heart; Heart Rate; Hemodynamics; Hypotension; Male; Mice; Mice, Knockout; Myocardial Contraction; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Vascular Resistance | 2004 |
Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension.
Topics: Animals; Arachidonic Acids; Blood Platelets; Cannabinoids; Cells, Cultured; Dronabinol; Endocannabinoids; Glycerides; Hypotension; Lipopolysaccharides; Macrophages; Male; Nitric Oxide; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 1998 |
Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice.
Topics: Anesthesia; Animals; Arachidonic Acids; Blood Pressure; Camphanes; Cardiovascular Agents; Cardiovascular Diseases; Dose-Response Relationship, Drug; Endocannabinoids; Female; Glycerides; Heart Rate; Hypotension; Indomethacin; Ligands; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Tachycardia | 2000 |